Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.8668
-0.0122 (-1.39%)
At close: Apr 29, 2026, 4:00 PM EDT
0.8800
+0.0132 (1.52%)
After-hours: Apr 29, 2026, 7:42 PM EDT
RVPH Market Cap
RVPH has a market cap or net worth of $11.1 million as of April 29, 2026. Its market cap has decreased by -64.79% in one year.
Market Cap
11.10M
Enterprise Value
-2.98M
1-Year Change
-64.79%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since October 18, 2018, RVPH's market cap has decreased from $25.21M to $11.10M, a decrease of -55.95%. That is a compound annual growth rate of -10.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 11.26M | -65.46% |
| Dec 31, 2025 | 32.60M | -61.33% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kairos Pharma | 11.82M |
| CytoMed Therapeutics | 11.71M |
| Psyence Biomedical | 11.65M |
| BioLineRx | 11.47M |
| PMGC Holdings | 11.26M |
| CDT Equity | 10.93M |
| Cellectar Biosciences | 10.85M |
| Quoin Pharmaceuticals | 10.70M |